1. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Gronning M (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis:a consensus report. J Neurol Neurosurg Psych 57: 897– 902
2. Andreasen N, Minthon L, Clarberg A, Davidsson P, Gottfries J, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K (1999) Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology 53: 1488–1494
3. Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerpints. Electrophoresis 20: 3521– 3526
4. Boyles JK, Notterpek LM, Anderson LJ (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. J Biol Chem 265: 17805– 17815 Brackenridge CJ, Jones IH (1972) Group-specific component and haptoglobin distributions in schizophrenic states. Clin Genet 3: 325–333
5. Csaszar A, Kalman J, Szalai C, Janka Z, Romics L (1997) Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer’s disease. Neurosci Lett 230: 150–154 Davidsson P, Paulson L, Hesse C, Blennow K, Nilsson CL (2001) Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 1: 444–452